Suzhou Basecare Medical Corp. Ltd. Class H (2170) Stock Statistics & Valuation Metrics

Suzhou Basecare Medical Corp. Ltd. Class H has a market cap or net worth of HK$382.94M. The enterprise value is HK$393.16.

Suzhou Basecare Medical Corp. Ltd. Class H has 82,713,840 shares outstanding. The number of shares has decreased by -2.65% in one year.

Suzhou Basecare Medical Corp. Ltd. Class H’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -16.33%.

The current PE Ratio of Suzhou Basecare Medical Corp. Ltd. Class H is ―. Suzhou Basecare Medical Corp. Ltd. Class H’s PEG ratio is 0.35.

In the last 12 months, Suzhou Basecare Medical Corp. Ltd. Class H had revenue of 233.27M and earned -223.46M in profits. Earnings per share was -0.82.

In the last 12 months, operating cash flow was -167.88M and capital expenditures -85.57M, giving a free cash flow of -253.45M billion.

Suzhou Basecare Medical Corp. Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Suzhou Basecare Medical Corp. Ltd. Class H upcoming earnings date is Aug 31, 2026, TBA (Confirmed).

Suzhou Basecare Medical Corp. Ltd. Class H as a current ratio of 3.98, with Debt / Equity ratio of 36.74%

In the past 12 months, Suzhou Basecare Medical Corp. Ltd. Class H has paid 3.74M in taxes.

Suzhou Basecare Medical Corp. Ltd. Class H EV to EBITDA ratio is -2.28, with an EV/FCF ratio of -1.57.

Suzhou Basecare Medical Corp. Ltd. Class H has HK$443.02M in cash and marketable securities with HK$343.36M in debt, giving a net cash position of HK$99.66M billion.

Gross margin is 52.99%, with operating margin of -91.77%, and net profit margin of -95.79%.

The average price target for Suzhou Basecare Medical Corp. Ltd. Class H is HK$1.60, which is 11.43% higher than the current price. The consensus rating is Moderate Buy